Author

Chul Kim

Institution: Georgetown University

Observed institution: Georgetown University

OpenAlex ID: A5137094040

First-in-human trial of BH-30643, a novel macrocyclic, non-covalent, mutant-selective OMNI-EGFR inhibitor, in EGFR -mutant ( EGFR m) NSCLC.

2026 · Xiuning Le, Alexander I. Spira, et al. · Journal of Clinical Oncology · 2

Works count: 1

Citation count: 2

H-index: 1

I10-index: